Crowdonomics
WatchlistPortfolio
This isn’t Aphios Pharma’s most recent raise. Reg CF · Common Stock · Oct 2024 (Closed) is more current.View latest round
Aphios Pharma

Reg CF · SAFE · Oct 2021

ClosedReached targetReg CFSAFE
via WeFunderView campaign
Raised
$97K / $1M max
10% of ceiling · target hit day 1
Investors
88
$1.1K avg
Valuation cap
$71M
cap, not an agreed valuation

Raised over time

Cumulative raisedInvestors
$111K$56K$0
88440
Oct 5, 2021 · openedJul 31, 2022 · last reading
Target ($50K) hit — Oct 6, 2021, day 1Deadline Apr 30, 2022

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via WeFunder; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2019–FY2020 · hover for source
$0
−$3K
FY2019
$0
−$16K
FY2020
RevenueNet income
Metric
FY2019
FY2020 audited
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$3,255
-$15,935
Taxes paid
$0
$0
Balance sheet
Cash
$1,524
$1,386
Accounts receivable
$42,112
$25,915
Total assets
$43,635
$27,301
Short-term debt
$400
$0
Long-term debt
$0
$0
Total liabilities
$400
$0
Other
Headcount
5
12

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

1 amendment
  1. Apr 22, 2022
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

Valuation cap$71M ($70M early bird)
Conversion discount10%

Perks

First $100K will invest in a SAFE with a $70M valuation cap and 10% discountfirst $100K

Offering details

Target$50,000
Max$1,000,000
Min investment$250
OpenedOct 5, 2021
DeadlineApr 30, 2022
ClosedJul 31, 2022
Days active299

Links & provenance

Campaign pageSEC filing
Source: Manual
0001670254-21-001105

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.